SceneRay obtains CE mark for Aaxon ND deep brain stimulation system in May of 2020.

After more than 3 years's full quality system evaluation, Dekra, grants the right to use the EC Notified Body Identification Number of 0344 to accompany the CE Marking of Conformity on the products concerned conforming to the required Technical Documentation and meeting the provisions of the EC-Directive.

Four major innovative technologies: bilateral different frequency stimulation, TouchLoc? lead fixture technology, wireless and high speed programming technology, wireless remote programming follow-up technology constitute unique Aaxon ND Deep Brain Stimulation System, which has been implanted in more than 10 countries, have brought significant efficacy and convenience for the patients suffering from Parkinson’s disease and other movement disorders. After CE approval, with more rigorous quality management, this advanced DBS system would serve more friends all over the world.